Seoulin Bioscience Co.,Ltd. (KOSDAQ:038070)

South Korea · Delayed Price · Currency is KRW

7,780.00

-80.00 (-1.02%)

Last updated: Jul 21, 2025

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2005 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2005 - 2019
Biotechnology	73.10B	Log In	Log In	Log In	Log In	Upgrade
Biotechnology Growth	-15.37%	Log In	Log In	Log In	Log In	Upgrade
Healthcare	2.31B	Log In	Log In	Log In	Log In	Upgrade
Healthcare Growth	-29.29%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2005 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2005 - 2019
South Korea	75.41B	Log In	Log In	Log In	Log In	Upgrade
South Korea Growth	-15.81%	Log In	Log In	Log In	Log In	Upgrade